Accord is committed to putting user safety at the heart of our offering. Accord is a dynamic young company unencumbered by past practice and with an appetite for refreshing the way in which safe and efficacious pharmaceuticals are delivered to users, adding innovative features to our concepts and products.
Accord’s corporate social responsibility goes beyond our contribution to environment through the application of regulations that favours its sustainability. Our contribution is directed as well to community and specifically to healthcare professionals and patients.
By recognising that our infrastructure must always be appropriate to solving the problem at hand, we have taken a novel approach to our supply of medicines in the fragmented market of Europe.
Rather than simply imitating what has gone before we try to take a more inventive approach to product development. As an example we have recently reformulated Gemcitabine into a highly concentrated form.